Strength
5 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714010001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA206662On Market Since
3/31/2021
Pharmacological Classes
Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Related Drugs
Same classification
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00378204501•Mylan Pharmaceuticals Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00781210201•Sandoz Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00904662361•Major Pharmaceuticals
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
16729004101•Accord Healthcare Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
51079081720•Mylan Institutional LLC
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
55111052501•Dr. Reddy's Laboratories Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
59746079801•Jubilant Cadista Pharmaceuticals Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
64380072006•Strides Pharma Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
67877027801•Ascend Laboratories, LLC
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
68084044901•American Health Packaging
$0.1512
per EA